Freestone Grove Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Freestone Grove Partners's ACLS Position: Q2 2026 in Review
Freestone Grove Partners reduced its Axcelis (ACLS) stake by 82% in Q2 2026, selling an estimated $859K and leaving 1,228 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #786.
Freestone Grove Partners first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. The position peaked at $653K in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Freestone Grove Partners held 1,228 shares of Axcelis worth $233K as of Q2 2026.
- Freestone Grove Partners sold 5,789 Axcelis shares in Q2 2026, an estimated $859K.
- Axcelis made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #786 holding.
- Freestone Grove Partners first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
- Freestone Grove Partners's Axcelis position peaked at $653K in Q1 2026.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.